← FDA DRUG APPROVALS

FDA ANDA · ANDA040309

HYDROCODONE BITARTRATE AND ACETAMINOPHEN

Sponsor: BARR

APPLICATION
ANDA040309
TYPE
ANDA
ORIGINAL APPROVAL
2000-07-26
LATEST ACTION
2001-08-23
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

HYDROCODONE BITARTRATE AND ACETAMINOPHENDiscontinued
ACETAMINOPHEN 500MG, HYDROCODONE BITARTRATE 10MG · TABLET · ORAL

Approval history

2001-08-23Manufacturing (CMC) · Supplement 1AP
2000-07-26Original — Label ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →